Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Blumenthal

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Cancer|February 1, 1994
Cytokine intervention permits dose escalation of radioantibody. An analysis of myelostimulation by bolus versus continuous infusion of IL-1/GM-CSFR D Blumenthal, R M Sharkey, D Forman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-pR D Blumenthal, R Kashi, R Stephens, et al.
International Journal of Cancer|July 3, 1997
Application of cytokine intervention for improved radio-antibody dose deliveryR D Blumenthal, R M Sharkey, L Haywood, et al.
International Journal of Cancer|December 15, 1989
Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograftR D Blumenthal, R M Sharkey, R Kashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenograftsR D Blumenthal, C Waskewich, D M Goldenberg, et al.
International Journal of Cancer|July 30, 1992
Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomasR D Blumenthal, R M Sharkey, R Kashi, et al.
Cancer|January 21, 2000
Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapyR D Blumenthal, W Lew, M Juweid, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997
Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenograftsR D Blumenthal, R M Sharkey, R Kashi, et al.
Journal of Surgical Oncology|October 1, 1988
Mouse ovarian tumor cells: an experimental model for progestin-mediated radiotherapyR D Blumenthal, W H McLaughlin, J J Jordan, et al.
Journal of Steroid Biochemistry|October 1, 1989
[125I]iodotamoxifen cytotoxicity in cultured human (MCF-7) breast cancer cellsW H McLaughlin, K M Pillai, J P Edasery, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cancer|February 1, 1994
Cytokine intervention permits dose escalation of radioantibody. An analysis of myelostimulation by bolus versus continuous infusion of IL-1/GM-CSFR D Blumenthal, R M Sharkey, D Forman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-pR D Blumenthal, R Kashi, R Stephens, et al.
International Journal of Cancer|July 3, 1997
Application of cytokine intervention for improved radio-antibody dose deliveryR D Blumenthal, R M Sharkey, L Haywood, et al.
International Journal of Cancer|December 15, 1989
Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograftR D Blumenthal, R M Sharkey, R Kashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenograftsR D Blumenthal, C Waskewich, D M Goldenberg, et al.
International Journal of Cancer|July 30, 1992
Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomasR D Blumenthal, R M Sharkey, R Kashi, et al.
Cancer|January 21, 2000
Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapyR D Blumenthal, W Lew, M Juweid, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997
Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenograftsR D Blumenthal, R M Sharkey, R Kashi, et al.
Journal of Surgical Oncology|October 1, 1988
Mouse ovarian tumor cells: an experimental model for progestin-mediated radiotherapyR D Blumenthal, W H McLaughlin, J J Jordan, et al.
Journal of Steroid Biochemistry|October 1, 1989
[125I]iodotamoxifen cytotoxicity in cultured human (MCF-7) breast cancer cellsW H McLaughlin, K M Pillai, J P Edasery, et al.
Pageof 6